Immunogenicity of IRIV- versus alum-adjuvanted diphtheria and tetanus toxoid vaccines in influenza primed mice

被引:35
|
作者
Zurbriggen, R [1 ]
Glück, R [1 ]
机构
[1] Swiss Serum & Vaccine Inst, CH-3001 Bern, Switzerland
关键词
adjuvants; virosomes; tetanus; diphtheria;
D O I
10.1016/S0264-410X(98)00361-2
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The immunogenicity and protectivity of two different toroid vaccines were compared in mice. In one formulation, toxoids (diphtheria or tetanus) were adsorbed to alumoxid, whereas in the other formulation the toxoids were crosslinked to immunopotentiating reconstituted influenza virosomes (IRIVs). A preimmunization with influenza antigens is necessary for a good anti-toroid antibody response when the IRIV formulation was administered. After two immunizations with the IRIV- or alum-based vaccines, the IRIV-based formulation induced a higher humoral immune response than toxoids adsorbed to alum. Using an in vitro test, diphtheria toxin neutralizing antibodies were tested. Di-IRIV induced a significantly (p = 0.002) higher titer of diphtheria toxin neutralizing antibodies than Di-alum. Tetanus challenge experiments showed, that the IRIV-based tetanus vaccine induced a threefold higher titer of protective antibodies than the tetanus toroid adsorbed to alum. Therefore, the IRIV-based formulations appeared to be superior to the alum-based vaccines in terms of immunogenicity and protectivity. (C) 1999 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1301 / 1305
页数:5
相关论文
共 28 条
  • [21] Safety and immunogenicity of tetravalent pneumococcal vaccines containing 6B, 14, 19F and 23F polysaccharides conjugated to either tetanus toxoid or diphtheria toxoid in young infants and their boosterability by native polysaccharide antigens
    Dagan, R
    Melamed, R
    Zamir, O
    Leroy, O
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1997, 16 (11) : 1053 - 1059
  • [22] CONTROLLED TRIAL OF HAEMOPHILUS-INFLUENZAE TYPE-B DIPHTHERIA TOXOID CONJUGATE COMBINED WITH DIPHTHERIA, TETANUS AND PERTUSSIS VACCINES, IN 18-MONTH-OLD CHILDREN, INCLUDING COMPARISON OF ARM VERSUS THIGH INJECTION
    SCHEIFELE, D
    BJORNSON, G
    BARRETO, L
    MEEKISON, W
    GUASPARINI, R
    VACCINE, 1992, 10 (07) : 455 - 460
  • [23] Immunogenicity and Safety of Human Papillomavirus-16/18 AS04-adjuvanted Vaccine Coadministered With Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine and/or Meningococcal Conjugate Vaccine to Healthy Girls 11 to 18 Years of Age Results From a Randomized Open Trial
    Wheeler, Cosette M.
    Harvey, Bryan M.
    Pichichero, Michael E.
    Simon, Michael W.
    Combs, Stephen P.
    Blatter, Mark M.
    Marshall, Gary S.
    Catteau, Gregory
    Dobbelaere, Kurt
    Descamps, Dominique
    Dubin, Gary
    Schuind, Anne
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2011, 30 (12) : E225 - E234
  • [24] Safety and immunogenicity of concomitant versus nonconcomitant administration of hepatitis B, tetanus-diphtheria, and measles-mumps-rubella vaccines in healthy eleven to twelve-year-olds
    Cassidy, WM
    Jones, G
    Williams, K
    Deforest, A
    Forghani, B
    Virella, G
    Venters, C
    JOURNAL OF ADOLESCENT HEALTH, 2005, 36 (03) : 187 - 192
  • [25] The safety and immunogenicity of a MF59- adjuvanted H5N1 prepandemic influenza vaccine in healthy adults primed with homologous or heterologous H5N1 vaccines: An observational study
    Wei S.-H.
    Liu M.-T.
    Tsai Y.-C.
    Liao C.-H.
    Chen C.-M.
    Wang W.-Y.
    Huang Y.-L.
    Chang F.-Y.
    Chou P.
    BMC Infectious Diseases, 14 (1)
  • [26] The safety and immunogenicity of a MF59-adjuvanted H5N1 prepandemic influenza vaccine in healthy adults primed with homologous or heterologous H5N1 vaccines: an observational study
    Wei, Sung-Hsi
    Liu, Ming-Tsan
    Tsai, Yao-Chou
    Liao, Chung-Hsin
    Chen, Chih-Ming
    Wang, Wei-Yao
    Huang, Yi-Lung
    Chang, Feng-Yee
    Chou, Pesus
    BMC INFECTIOUS DISEASES, 2014, 14
  • [27] Comparison of Immunogenicity and Safety of Diphtheria-Tetanus-Pertussis-Hepatitis B-Haemophilus influenza B (Bio Farma) with Pentabio(R) Vaccine Primed with Recombinant Hepatitis B at Birth (Using Different Source of Hepatitis B) in Indonesian Infants
    Fadlyana, Eddy
    Rusmil, Kusnandi
    Dhamayanti, Meita
    Tarigan, Rodman
    Kartasasmita, Cissy B.
    Sari, Rini Mulia
    Putra, Muhammad Gilang Dwi
    Sukandar, Hadyana
    VACCINES, 2023, 11 (03)
  • [28] Immunogenicity and safety of a booster dose of diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccine (Tdap-IPV, Repevax®) administered concomitantly versus non-concomitantly with an influenza vaccine (Vaxigrip®) to adults aged ≥60 years: An open-label, randomised trial
    Zimmermann, Ulrich
    Gavazzi, Gaetan
    Richard, Patrick
    Eymin, Cecile
    Soubeyrand, Benoit
    Baudin, Martine
    VACCINE, 2013, 31 (11) : 1496 - 1502